# Early Recanalization After Intravenous Thrombolysis With Tenecteplase Versus Alteplase in Distal Vessel Occlusion Strokes

> **NCT05635786** · — · COMPLETED · sponsor: **Centre Hospitalier Sud Francilien** · enrollment: 319 (actual)

## Conditions studied

- Acute Distal Vessel Occlusion Stroke

## Interventions

- **DRUG:** Alteplase (0.9mg/kg)
- **DRUG:** Tenecteplase (0.25mg/kg)

## Key facts

- **NCT ID:** NCT05635786
- **Lead sponsor:** Centre Hospitalier Sud Francilien
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-02
- **Primary completion:** 2024-11-21
- **Final completion:** 2024-11-21
- **Target enrollment:** 319 (ACTUAL)
- **Last updated:** 2025-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05635786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05635786, "Early Recanalization After Intravenous Thrombolysis With Tenecteplase Versus Alteplase in Distal Vessel Occlusion Strokes". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05635786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*